Purpose: The authors explored the empirical dosing requirement for administration of an alpha 2-adrenoceptor agonist, brimonidine, and determined its efficacy in decreasing elevations in intraocular pressure (IOP) after 360 degrees argon laser trabeculoplasty (ALT).
Methods: This vehicle-controlled, double-masked, multicenter trial evaluated three dosing regimens of brimonidine. Two hundred thirty-two patients for whom 360 degrees ALT was indicated were randomized into one of four treatment groups: 0.5% brimonidine both before and after ALT; brimonidine before but vehicle after ALT; vehicle before but brimonidine after ALT; or vehicle at both times.
Results: During the first 3 hours after 360 degrees ALT, the overall incidence of IOP elevations of 5 mmHg or greater was 38% (23 of 60 eyes) in the group receiving vehicle only, and it ranged from 3% to 9% (2 of 62 to 5 of 53 eyes) in the groups receiving any brimonidine treatment. There was little difference in efficacy between the three dosing regimens of brimonidine. Brimonidine was well tolerated by the patients.
Conclusion: Based on this large, controlled, multicenter study, 0.5% brimonidine was an effective agent for reducing elevations in IOP after 360 degrees ALT. Only one dose, administered either before or after 360 degrees ALT, was required.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0161-6420(93)31545-9 | DOI Listing |
Alzheimers Dement
December 2024
Universita Degli Studi Di Bergamo, Bergamo, Italy.
Background: Increasing findings have proven that virtual reality (VR) is a promising approach for improving knowledge, self-efficacy, and empathy in educational programs (Dhar, DigitHealth. 2023). The purpose of an ongoing randomised clinical trial is to enhance mental wellbeing of dementia patients' informal caregivers (iCGs) by including a VR-based empathy training into an online psychoeducation program.
View Article and Find Full Text PDFPLoS One
January 2025
Department of Civil, Urban, Earth and Environmental Engineering, Ulsan National Institute of Science and Technology, Ulsan, South Korea.
This study explores the perceived walkability of one-way commercial streets by utilizing immersive 360-degree virtual reality (VR) videos. While one-way roads are often introduced to facilitate smooth traffic flow on narrow roads, providing safe and walkable environments for pedestrians on the one-way roads is crucial, especially in commercial areas with heavy pedestrian traffic. We recruited 40 students to assess the perceived walkability of one-way roads based on ten VR scenarios.
View Article and Find Full Text PDFMicromachines (Basel)
December 2024
State Key Laboratory of Millimeter-Waves, School of Information Science and Engineering, Southeast University, Nanjing 210096, China.
This paper presents a D-band dual linear-polarized wideband high-gain reflectarray (RA) antenna using low-temperature co-fired-ceramic (LTCC) technology. The proposed element comprises a dual-polarized magnetoelectric (ME) dipole and a multilayer slot-coupling substrate-integrated waveguide (SIW) phase-delay structure, which are organized in accordance with the receiving/reradiating (R/R) principle. The coverage of phase shifts for both orthogonal polarizations is set to be greater than 360 degrees by varying the length of the phase-delay structure.
View Article and Find Full Text PDFSchizophr Bull
January 2025
Institute for Brain Research and Rehabilitation, South China Normal University, Guangzhou 510631, China.
Background And Hypothesis: Population-based morphological covariance networks are widely reported to be altered in schizophrenia. Individualized morphological brain network approaches have emerged recently. We hypothesize that individualized morphological brain networks are disrupted in schizophrenia.
View Article and Find Full Text PDFGeburtshilfe Frauenheilkd
January 2025
Klinik für Gynäkologie, Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!